Today, we’re tackling a question that maybe sounds straightforward, but could have complicated, unforeseen consequences. That question? What happens if the FDA stops collecting user fees from drug companies? At first glance, it sounds like a win. Less corporate influence, more independence for regulators. But is it really that simple? 

Read the full article

• The Cost of Free: What Removing FDA User Fees Could Mean for Drug Innovation and Public Health

About the author

• Matt Quinn, Ph.D.